Back to Search
Start Over
Su1739 RISANKIZUMAB, BUT NOT USTEKINUMAB OR VEDOLIZUMAB, DOWNREGULATES IL-23-INDUCED MUCOSAL PATHOGENIC TH17 CELLS IN PATIENTS WITH CROHN'S DISEASE.
- Source :
- Gastroenterology (00165085); 2024 Supplement, Vol. 166 Issue 5, pS-792-S-792, 1p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 00165085
- Volume :
- 166
- Issue :
- 5
- Database :
- Supplemental Index
- Journal :
- Gastroenterology (00165085)
- Publication Type :
- Academic Journal
- Accession number :
- 177028834
- Full Text :
- https://doi.org/10.1016/S0016-5085(24)02303-5